Hong Kong Biotech Stock News

SEHK:728
SEHK:728Telecom

A Look At China Telecom’s (SEHK:728) Valuation After Fresh GLOMO Recognition For Technology And Social Impact

Why China Telecom’s GLOMO wins are back on investors’ radar Fresh recognition for China Telecom (SEHK:728) at the 2026 Mobile World Congress, including multiple Global Mobile Awards tied to satellite connectivity and digital education, has put the stock back in focus for many investors. See our latest analysis for China Telecom. The recent GLOMO awards arrive as China Telecom’s share price trades at HK$5.1, with short term share price returns in positive territory but a 90 day share price...
SEHK:3933
SEHK:3933Pharmaceuticals

United Laboratories International Holdings (SEHK:3933) Valuation After Positive Phase 2 UBT251 Obesity Trial Results

Phase 2 UBT251 data puts obesity pipeline in focus United Laboratories International Holdings (SEHK:3933) has drawn fresh attention after its subsidiary completed a Chinese phase 2 trial of UBT251, a GLP-1, GIP and glucagon triple agonist for overweight and obesity. See our latest analysis for United Laboratories International Holdings. The phase 2 obesity data lands at a time when the share price has a 1 month share price return of 11.39% and a year to date share price return of 12.53%,...
SEHK:2343
SEHK:2343Shipping

A Look At Pacific Basin Shipping (SEHK:2343) Valuation After Full Year 2025 Earnings And Capital Return Update

Why Pacific Basin Shipping’s Latest Earnings Matter for Investors Pacific Basin Shipping (SEHK:2343) has just reported its full year 2025 results, with sales of US$2,081.04 million and net income of US$58.17 million, alongside commentary on shareholder returns and capital allocation. The company also pointed to a 46% total shareholder return, a new US$250 million sustainability linked facility, and an ongoing share buyback. Together, these factors frame how management is currently thinking...
SEHK:2268
SEHK:2268Life Sciences

WuXi XDC Cayman (SEHK:2268) Is Down 5.7% After Exclusive WuXiTecan-2 Licensing Deal – Has The Bull Case Changed?

In February 2026, Earendil Labs announced a collaboration with WuXi XDC Cayman Inc., securing an exclusive global license to WuXi XDC’s proprietary WuXiTecan-2 payload-linker platform for multiple targets, alongside up to approximately US$885 million in potential upfront and milestone payments plus tiered royalties. The partnership combines Earendil’s AI-driven antibody discovery with WuXi XDC’s integrated bioconjugate CRDMO capabilities, positioning WuXi XDC as a key enabler in...
SEHK:981
SEHK:981Semiconductor

Thai DR Listing Opens New Way To Assess SMIC Valuation And Momentum

Semiconductor Manufacturing International (SEHK:981) is now accessible to Thai investors via newly listed depositary receipts on the Stock Exchange of Thailand. The DRs give investors in Thailand indirect exposure to SMIC shares that trade in Hong Kong at around HK$61.8. This cross border listing move broadens access to SMIC equity and may affect trading activity in its Hong Kong listed shares over time. For you as an investor, the new Thai DRs open another route into Semiconductor...
SEHK:2145
SEHK:2145Personal Products

Shanghai Chicmax Cosmetic (SEHK:2145) Valuation Check After Strong 2025 Growth Guidance

Shanghai Chicmax Cosmetic (SEHK:2145) issued unaudited guidance for 2025, projecting revenue of RMB 9,100.0 million to RMB 9,200.0 million and profit of RMB 1,140.0 million to RMB 1,160.0 million, highlighting momentum across its key brands. See our latest analysis for Shanghai Chicmax Cosmetic. The upbeat 2025 guidance sits against a mixed share price backdrop, with a 7% 1 day share price return and a 1 year total shareholder return of 68.27%. At the same time, the 90 day share price return...
SEHK:6618
SEHK:6618Consumer Retailing

Assessing JD Health International’s Valuation After Strong 2025 Sales And Net Income Growth

JD Health’s latest earnings and why they matter JD Health International (SEHK:6618) has just reported its full year 2025 results, with sales of CNY 73,441.49 million and net income of CNY 5,375.41 million, catching investor attention. See our latest analysis for JD Health International. JD Health International’s full year earnings arrive at a time when the 1-year total shareholder return of 35.38% contrasts with a 20.20% 30-day share price decline and a 19.60% 90-day share price decline,...
SEHK:1113
SEHK:1113Real Estate

A Look At CK Asset Holdings (SEHK:1113) Valuation As Board Prepares Dividend And Results Decision

CK Asset Holdings (SEHK:1113) has set a date for its next key catalyst, with the board scheduled to meet in Hong Kong on 19 March 2026 to approve the 2025 annual results and consider a final dividend. See our latest analysis for CK Asset Holdings. At a share price of HK$47.9, CK Asset Holdings has seen a 30 day share price return of 4.27% and a 90 day share price return of 17.40%, with a 1 year total shareholder return of 42.02%. This performance may lead some investors to reassess the stock...
SEHK:69
SEHK:69Hospitality

Assessing Shangri-La Asia (SEHK:69) Valuation After New Final And Proposed Dividend Announcements

Dividend announcements put Shangri-La Asia in focus Shangri-La Asia (SEHK:69) has drawn investor attention after announcing a final single tier dividend of HK$0.06 per share for FY2025, together with a proposed THB0.50 per share payout pending shareholder approval. The Hong Kong dollar dividend is scheduled for payment on June 29, 2026, with an ex dividend date of June 9 and an entitlement date of June 10, while the Thai baht proposal totals THB65 million. See our latest analysis for...
SEHK:1913
SEHK:1913Luxury

Prada (SEHK:1913) Margins Hold Near 14.9% Keeping Bullish Earnings Narratives In Focus

How Prada (SEHK:1913) Just Performed Prada (SEHK:1913) has released its FY 2025 numbers with first half revenue at €2.7 billion and basic EPS of €0.15, setting the tone for how the rest of the year may shape up for the luxury group. The company has seen revenue move from €2.5 billion and EPS of €0.15 in 1H 2024 to €2.7 billion and EPS of €0.18 in 2H 2024, finishing the trailing twelve months with €5.7 billion of revenue and EPS of €0.33. With a trailing net profit margin of 14.9% and growth...
SEHK:373
SEHK:373Consumer Finance

Allied Group (SEHK:373) Valuation Check After Leadership Change And Strong 1 Year Shareholder Returns

Allied Group (SEHK:373) is in focus after the board announced that long serving executive director Mr. Edwin Lo King Yau will retire. Director of investment Mr. Mark Wong Tai Chun will assume board and representative roles. See our latest analysis for Allied Group. The leadership reshuffle comes after a strong run in the shares, with Allied Group’s 30 day share price return of 16.26% and 90 day share price return of 50.67%, while its 1 year total shareholder return of 131.72% suggests recent...
SEHK:9992
SEHK:9992Specialty Retail

Assessing Pop Mart International Group’s Rich Valuation After Strong Recent Shareholder Returns

What Pop Mart’s recent share performance tells you With no single headline event driving attention to Pop Mart International Group (SEHK:9992) right now, recent price moves and financial figures offer a useful snapshot of how the market is treating the stock. See our latest analysis for Pop Mart International Group. At the latest share price of HK$207.4, the stock’s short term momentum looks softer, with a 7 day share price return of 9.75% and 30 day share price return of 12.56%, while the 1...
SEHK:1398
SEHK:1398Banks

A Look At Industrial And Commercial Bank Of China’s Valuation As Beijing Plans Capital Injection Into State Banks

Government capital plan puts ICBC back in focus Industrial and Commercial Bank of China (SEHK:1398) has moved back into the spotlight after Beijing outlined a planned ¥300b capital injection into state owned banks through special treasury bonds and broader financial sector reforms. With investors watching how support may be allocated across the system, attention is turning to what this could mean for ICBC’s capital position, risk bearing capacity, and the way it manages exposure to property...
SEHK:2386
SEHK:2386Construction

The Bull Case For SINOPEC Engineering (Group) (SEHK:2386) Could Change Following 2025 Results Review And Dividend Plan - Learn Why

SINOPEC Engineering (Group) has announced that its board will meet on 13 March 2026 to review and approve the company’s 2025 annual results and consider a dividend distribution plan, which will later be submitted to shareholders at the annual general meeting. This upcoming board decision is important because it will pair fresh financial disclosures with a potential dividend proposal, giving investors clearer information on how the board is balancing capital returns and future investment...
SEHK:1211
SEHK:1211Auto

Is It Time To Reassess BYD (SEHK:1211) After A 19% One Year Share Price Decline

If you are trying to figure out whether BYD’s current share price makes sense, you are in the right place. This article focuses on what the numbers say about value rather than the hype around electric vehicles. BYD last closed at HK$94.70, with returns of 5.2% over 30 days, a 19.1% decline over 1 year and gains of 45.6% over 3 years and 53.5% over 5 years. This gives a mixed picture of recent price momentum and changing risk sentiment. Recent coverage around BYD has focused on its position...
SEHK:386
SEHK:386Oil and Gas

China Export Ban Tests China Petroleum And Chemical’s Growth And Valuation Narrative

China has imposed an urgent ban on diesel and gasoline exports by state oil giants, including China Petroleum & Chemical (Sinopec), in response to escalating geopolitical tensions involving the US, Israel, and Iran. The suspension affects shipments to regional buyers and could tighten fuel supplies across the Asia Pacific market. The move marks a major shift in operating flexibility for SEHK:386, which has been a key supplier of refined products to neighboring economies. For China Petroleum...
SEHK:2228
SEHK:2228Life Sciences

XtalPi Targets 2025 Profitability As DoveTree Deal Reshapes Growth Outlook

XtalPi Holdings (SEHK:2228) has outlined a plan to reach profitability in 2025. Management links the shift to tripled revenue and improved performance in core businesses. A multi billion dollar collaboration with DoveTree is cited as a key factor in the updated outlook. The company highlights gains from recent partnerships as part of its 2025 profitability plan. XtalPi Holdings operates at the intersection of technology and biopharma, focusing on drug discovery and related services. For...
SEHK:9999
SEHK:9999Entertainment

NetEase Dual Listing May Unlock Stock Connect Access And Valuation Gap

NetEase (SEHK:9999) is shifting from a secondary to a dual-primary listing on the Hong Kong Stock Exchange. The new structure is expected to qualify the company for potential inclusion in the Stock Connect program. Mainland Chinese investors would gain direct access to NetEase shares traded in Hong Kong for the first time. NetEase runs a large online games and internet services business, with operations that span PC and mobile titles, online learning, and other digital platforms. The move...
SEHK:916
SEHK:916Renewable Energy

China Longyuan Power Group (SEHK:916) Valuation Update After February 2026 Power Generation Data

China Longyuan Power Group (SEHK:916) caught investor attention after reporting February 2026 power generation figures, with overall output edging up, wind output softening, and solar capacity continuing to contribute a higher share. See our latest analysis for China Longyuan Power Group. That February update comes after a strong run in the share price, with a 30 day share price return of 15.36% and a year to date share price return of 17.75% at a latest share price of HK$7.96. The 1 year...
SEHK:2171
SEHK:2171Biotechs

CARsgen Therapeutics (SEHK:2171) Loss Narrows To C¥75m In 1H 2025 Challenging Bearish Narratives

CARsgen Therapeutics Holdings (SEHK:2171) opened FY 2025 with first half revenue of C¥51.0 million and a basic EPS loss of C¥0.14, while trailing 12 month figures show revenue of C¥84.0 million and a basic EPS loss of C¥0.95. The company reported revenue of C¥6.3 million in 1H 2024, C¥33.1 million in 2H 2024 and C¥51.0 million in 1H 2025, with basic EPS losses of C¥0.63, C¥0.81 and C¥0.14 across those respective periods. Investors are likely to focus on how margins develop from here and how...
SEHK:2299
SEHK:2299Luxury

Billion Industrial Holdings (SEHK:2299) Valuation As Board Weighs 2025 Results And Potential Final Dividend

Billion Industrial Holdings (SEHK:2299) has called a board meeting for 16 March 2026 to approve its audited 2025 final results and to consider a potential final dividend, which is a key focus for income oriented investors. See our latest analysis for Billion Industrial Holdings. The recent announcement has come after a period where the 1 year total shareholder return of 8.9% contrasts with a weaker year to date share price return of a 4.5% decline. This hints that earlier momentum has cooled...
SEHK:51
SEHK:51Real Estate

Harbour Centre Development (SEHK:51) Deeper EPS Loss Tests Patient Bull Narratives

Harbour Centre Development (SEHK:51) FY 2025 earnings snapshot Harbour Centre Development (SEHK:51) has posted its FY 2025 first half results with revenue of HK$654 million and a basic EPS loss of HK$0.28, keeping the focus squarely on how efficiently the business is converting its top line into profits. The company’s revenue increased from HK$623 million in the first half of FY 2024 to HK$654 million in the latest half. Over the same period, basic EPS moved from a loss of HK$0.01 in the...
SEHK:288
SEHK:288Food

Assessing WH Group (SEHK:288) Valuation After Strong Multi‑Year Shareholder Returns

Without a specific news headline driving attention today, WH Group (SEHK:288) still offers plenty to consider for investors who follow the global pork and packaged meats space and its recent share price performance. See our latest analysis for WH Group. At a share price of HK$9.79, WH Group has seen a 17.25% 90 day share price return, alongside a 64.32% 1 year total shareholder return and a 191.55% 3 year total shareholder return, which suggests momentum has been strong over multiple...
SEHK:700
SEHK:700Interactive Media and Services

Tencent Holdings (SEHK:700) Valuation Check After Recent Share Price Weakness

Tencent Holdings overview after recent share moves Tencent Holdings (SEHK:700) has attracted fresh attention after recent share price moves, with the stock last closing at HK$519. Investors are weighing this level against the group’s current earnings and business mix. See our latest analysis for Tencent Holdings. While Tencent’s 3.4% 1 day share price return has caught attention, the stock’s 30 day and year to date share price returns of 7.0% and 16.7% declines suggest momentum has cooled,...